Pregnancies complicated by suspected intrauterine growth restriction (IUGR) are usually monitored by Doppler ultrasound to measure fetal blood flow. A pattern of absent or reversed enddiastolic flow velocity (AREDFV) in the umbilical artery is associated with fetal growth restriction and increased risk of intrauterine death. 1, 2 Management of such complicated pregnancies often results in the preterm delivery of a growth-restricted infant. The authors of studies suggest that blood flow to the head is preserved to support brain growth at the expense of blood flow to the abdomen and growth of visceral organs. 1, 3, 4 Increasing use of Doppler ultrasound in clinical practice has revealed an association between AREDFV and necrotizing enterocolitis (NEC), thought to be a result of this relative gut ischemia. 5, 6 A meta-analysis of 14 observational studies confirmed an increased incidence of NEC in preterm infants who had exhibited fetal AREDFV compared with controls, with an odds ratio of 2.13 (95% confidence interval [CI]: 1.49-3.03). 7 As NEC mostly occurs after infants have received enteral feeds, it has become common practice to delay the start of enteral feeding in those considered to be at highest risk. 8 The evidence base to support this practice is weak, particularly as authors of published studies frequently do not give clarity on fetal growth restriction. In interpreting other studies, we have defined small for gestational age (SGA) as birth weight below 10th centile, which may include some small-normal infants. IUGR defines those infants who have a history of abnormal antenatal Doppler blood flow, indicating a pathologic reduction in growth below their genetic potential; these infants are frequently, but not necessarily, also SGA. A Cochrane review of early or late commencement of progressive enteral feeds for preterm infants published in 2008 identified 3 small trials with 115 participants. All infants were preterm and low birth weight but were not specifically SGA or IUGR. "Early" feeds were started within 4 days of birth, and "late" feeds between 5 and 10 days. No difference was seen in rates of NEC, but the authors concluded that the available data were insufficient to inform clinical practice. 9 The authors of 1 published trial have specifically investigated early or late feeding of SGA IUGR infants born after abnormal Dopplers. 10 Eighty-four infants were randomly assigned to start feeds either before or after 5 days after birth; no difference was found in incidence of NEC or feed intolerance. An updated Cochrane review published in 2011 incorporated data from this study, as well as incomplete data from our study, 11 thus combining data from IUGR, SGA, and appropriate for gestational age infants. With a total of 600 infants, their conclusion regarding NEC was unchanged. 12 Postnatal growth restriction is common in preterm infants and is associated with adverse neuro-developmental outcomes. 13 Limited published evidence suggests that severe IUGR is associated with an increased risk of neurodevelopmental impairment. 14 Early introduction of enteral feeds may improve nutrition and growth and subsequent outcomes but may increase the risk of NEC. 15, 16 Conversely, late introduction may result in villous atrophy and reduced hormone and enzyme production 17 due to lack of intestinal stimulation. Late introduction may also result in prolonged use of parenteral nutrition with increased risks of sepsis, 16 cholestatic jaundice, 18, 19 and vitamin and mineral deficiencies.
Advances in fetal medicine have resulted in increased numbers of infants being born preterm after AREDFV, but there is a paucity of robust data on which to base feeding practice. IUGR infants have often been specifically excluded from preterm infant feeding studies because of their perceived high risk status. 20, 21 The Abnormal Doppler Enteral Prescription Trial (ADEPT) was designed to evaluate the effect of an early compared with a late enteral feeding regimen on the time to establish full enteral feeding and incidence of NEC and other gastrointestinal complications in a group of SGA, IUGR infants identified by antenatal Doppler studies.
METHODS

Trial Design and Participants
ADEPT was a multicenter randomized controlled trial, and the methods are reported in full in the published protocol. 22 Infants were eligible if they were born preterm (up to 34 +6 weeks of gestation), SGA (birth weight below 10th centile 23 ), ,48 hours postnatal age, and had abnormal antenatal Doppler studies indicative of IUGR. This was defined as the following: (1) AREDFV in the umbilical artery seen on at least 50% of waveforms on at least 1 occasion during pregnancy, or (2) cerebral redistribution (umbilical artery pulsatility index .95th centile and middle cerebral artery pulsatitility index ,5th centile for gestation). 24 Exclusion criteria were as follows: major congenital anomaly, twintwin transfusion, Rhesus iso-immunization, previous intrauterine or exchange transfusion, multiorgan dysfunction, inotropic drug support, or enteral feeding before trial entry. Informed written parental consent was obtained within the first 48 hours after birth.
Intervention
Infants were randomly allocated to early (between 24 and 48 hours after birth) or late (between 120 and 144 hours after birth) enteral feeding regimen, which was identical apart from the time it commenced. Feeds were gradually increased according to an "enteral prescription" tailored to birth weight, aiming to reach 150 mL/kg per day over 13 days in the smallest infants (,600 g) and 9 days in the largest infants (.1250 g). 22 It was expected that parenteral nutrition would be started within 24 to 48 hours of birth and continued until milk feeding established. Mother' s breast milk was recommended as the first choice of initial milk, followed by donor breast milk and infant formula. Fortification of human milk was recommended once 150 mL/kg per day was reached, if additional nutrient support was required. Ventilation support or presence of umbilical catheters was not viewed as a contraindication to feeding.
Outcomes
Primary outcomes were (1) age in days to achieve full enteral feeding of at least 150 mL/kg per day sustained for 72 hours and (2) a diagnosis of NEC (modified Bell' s stage 1, 2, or 3). 25 Intake was recorded daily on a feed log, and full feeds had to be sustained for 72 hours to ensure genuine milk tolerance.
Secondary outcomes were as follows: death before hospital discharge; duration of hospital stay, intensive care, highdependency care (defined in protocol 22 ), and parenteral nutrition; gastrointestinal perforation; gastrointestinal surgery; culture-positive sepsis; patent ductus arteriosus requiring treatment; cholestasis (conjugated bilirubin .25 mmol/liter*); cranial ultrasound abnormality (ventricular dilatation $4 mm above 97th centile, parenchymal hemorrhage or infarct, cystic periventricular leukomalacia); type of milk at discharge; and oxygen therapy, weight, and head circumference at 36 weeks' postmenstrual age and at discharge.
A designated form was completed for each episode of NEC or other abdominal pathology. Local investigators were asked to document clinical signs and laboratory, radiologic, and histopathologic findings, and to make a "final diagnosis" for each episode. All forms were reviewed by a blinded committee.
Sample Size
Unpublished nutrition data from a UK regional database of very low birth weight infants 26 revealed an SD of 9 days in the time taken to reach full enteral feeding. We calculated that 380 infants would be required to show a difference of 3 days in this outcome with 90% power. The incidence of NEC from published literature is ∼15% in this population, and a sample of 400 would be sufficient to show a 50% change in the incidence of NEC with 60% power.
Randomization
Infants were randomly assigned between 20 and 48 hours after birth by using a secure Web-based randomization service hosted by the National Perinatal Epidemiology Unit Clinical Trials Unit. A minimization algorithm was used to ensure a balanced allocation within hospital of recruitment, gestational age group (,29 weeks or $29 weeks), and type of Doppler abnormality (AREDFV or cerebral redistribution).
Blinding
Masking clinicians to allocation was not possible. However, a blinded committee reviewed all NEC and abdominal pathology forms, as well as any cases where there was uncertainty about the primary end point being met. 22 
Statistical Methods
Infants were analyzed in their allocated group by using Stata (version 10; Stata Corp, College Station, TX), regardless of the feeding regimen they actually received or deviation from the protocol. A time to event analysis using Cox regression was performed to compare the age in days at which full enteral feeding was reached between the early and late group. This enables the infants who died before reaching full feeds to be included in the denominator (until the time they died). Kaplan-Meier curves were plotted and the hazard ratios (HRs) presented. Two-sided hypothesis tests and 95% CIs are presented throughout.
SD scores (SDSs) were calculated for growth data, and the change in SDS from birth to 36 weeks and discharge were analyzed by using analysis of covariance, adjusting for birth weight SDS. A prespecified subgroup analysis was planned by using a statistical test of interaction, stratifying by gestation at delivery (,29 or $29 weeks) and type of Doppler abnormality.
RESULTS
Recruitment and Retention
Four hundred four infants were recruited from April 2006 to May 2009 from 54 hospitals in the United Kingdom and Ireland (Fig 1) . Clinical characteristics at trial entry were well balanced between groups, though there was a slightly higher proportion of infants $1250 g in the early group (Table 1) .
Compliance With Introduction of Enteral Feeds
There was clear separation between groups in the distribution of time of first feed. Feeding started within the specified time for 164/198 (83%) infants in the early group and 147/194 (76%) infants in the late group. This increased to 87% and 86%, respectively, when a 2-hour tolerance was allowed during either side of the specified times. (Fig 2) . This indicates that the relative likelihood of establishing full feeds at any given time was 36% higher in the early group compared with the late group. The analysis was repeated adjusting for birth weight category (defined in Table 1 ) because there was a slight imbalance between groups, which could have explained some of the difference seen in feeding advancement. The adjusted HR was 1.45 (95% CI: 1.19-1.78; P , .001), which does not alter the conclusions of the main analysis.
The number of episodes of all-stage NEC was 36 (18%) in the early group and 30 (15%) in the late group (relative risk [RR]: 1.20 [95% CI: 0.77-1.87; P = .42]). The incidence of stages 2 and 3 NEC, which is of greater clinical importance, was 8% in both groups. More infants in the early group had at least 1 episode of "abdominal pathology": 59 (29%) vs 42 (21%; RR: 1.40 [95% CI: 1.00-1.98]), which was mainly due to a higher rate of dysmotility, meconium plug, and stage 1 NEC. There were no between-group differences in the number of infants with septic ileus, intestinal perforation, surgery, or death as a result of gastrointestinal complications.
Other Secondary Outcomes
Cholestatic jaundice was less common in the early group; 25/195 (13%) compared with 43/195 (22%; RR: 0.58 [95% CI: 0.37-0.91]; Table 3 ). The incidence of late onset sepsis was 55/198 (28%) in the early group and 69/199 (35%) in the (14) IQR (25th-75th percentile). a Unless otherwise specified.
FIGURE 1
Flow of participants. †The P value for the log-rank test was 0.002. late group, which was not statistically significant (RR: 0.80 [95% CI: 0.60-1.08]). Early feeding resulted in shorter duration of parenteral nutrition (amino acids and lipid) and high-dependency care, but there was no difference in overall length of hospital stay or duration of intensive care (Table 3) .
Infants were severely growth-restricted at birth with a mean weight SDS of 22.32 in the early group and 22.41 in the late group, and underwent a period of further postnatal growth restriction. By the time of discharge, weight SDS was still below birth levels in both groups, with a greater degree of postnatal growth restriction in the late group (P = .04). Head circumference revealed some "catch-up" growth, and there was no between-group difference. The statistical test of interaction between treatment group and gestational age was not significant for median age to achieve full feeds (P = .38) or for incidence of all-stage NEC (P = .47), implying consistency of treatment effect in the 2 subgroups for the primary outcomes.
Subgroup Analysis
Type of Doppler abnormality was predefined for subgroup analysis; however, because fewer than 5% of infants had a pattern of cerebral redistribution, this was not carried out.
DISCUSSION
Awareness that growth-restricted preterm infants are at high risk for feeding intolerance and NEC has led to a common practice of delaying the introduction of enteral feeds. Our results suggest that this practice is not justified. Infants in ADEPT who started feeds earlier achieved sustained enteral feeding at a significantly earlier age, with an average difference of 3 days. No difference was found in the incidence of NEC, particularly for serious Bell's stage 2 or 3. Rates of all-stage NEC at 18% in the early group and 15% in the late group were consistent with those found in our systematic review. 7 Although slightly more infants in the early feeding group had stage 1 NEC and intestinal dysmotility, there was no difference in the number requiring bowel surgery and no difference in death related to gastrointestinal complications.
Other related benefits of starting feeds earlier were a shorter duration of parenteral nutrition and of high-dependency care and a lower incidence of cholestatic jaundice. Among preterm infants receiving parenteral nutrition, those with IUGR and with sepsis are at particular risk of cholestasis. 27 Because cholestasis impairs fat absorption and may further compromise nutrition and growth, policies aimed at reducing it should be preferred. We found no significant difference in the incidence of late onset sepsis.
Our study infants were severely growth restricted at birth, being below the second centile for weight. After birth, they experienced further growth restriction such that at discharge their weight SDSs were lower than at birth. This reduction in SDS was significantly less marked in the early feeding group, allowing speculation that even a 3-day difference in establishment of enteral feeding may have a positive impact on growth.
This is the largest interventional study to date in this patient population, with IUGR related to antenatal AREDFV, but our findings are compatible with relevant published data. The study by Karagianni et al 10 has been discussed earlier.
Van Elberg et al 28 investigated early versus late introduction of "trophic feeding" in SGA preterm infants, most of whom had abnormal antenatal Doppler scans. Neither study revealed a difference in incidence of NEC or other clinical outcomes.
Trophic feeding has been suggested as a way of promoting intestinal adaptation and avoiding the adverse effects of total enteral fasting in infants at high risk for NEC. The authors of a systematic review summarized 9 trials, involving 754 preterm infants. 29 Seven trials defined eligibility by gestational age, birth weight, or both, appearing to include both appropriate for gestational age and SGA infants; 1 trial excluded those who were SGA, and 1 28 included only infants who were SGA. Meta-analysis did not demonstrate a significant effect on feed tolerance, weight gain, or NEC. 29 The authors' conclusion was that there were insufficient data to exclude either a harmful or beneficial effect of trophic feeding.
We recognize that ADEPT had only 60% power to detect a 50% difference in the incidence of NEC and did not show this.
What it has demonstrated, in keeping with other published work, is that the intervention of delaying feeds is unlikely to produce large effects. A negative trial with 90% power would require 6400 infants to exclude a difference in all-stage NEC rates of 18% vs 15%. We excluded infants receiving inotropes and those with perinatal complications likely to further compromise gut perfusion, so our findings may not be applicable to all infants born after AREDFV.
Introduction of a standardized feeding regimen has been shown to reduce the incidence of NEC compared with retrospective control groups. 30 The failure of our standardized "enteral prescription" to reduce NEC rates compared with previous published studies may be due to the large number of study centers and relatively small number of patients recruited from each. Breast milk has been shown to offer protection against NEC, 31,32 and we were reassured to observe that even in our early group, more than 75% of infants received their mother's breast milk at the initial feed.
CONCLUSIONS
Our trial revealed no evidence of benefit in delaying the introduction of small volumes of enteral feeds in preterm, IUGR infants beyond 24 to 48 hours. Early introduction allows establishment of full feeds earlier with a reduction in cholestatic jaundice and improved
FIGURE 2
Proportion of infants with full enteral feeding established by feeding group.
weight gain. The challenge now is to understand how best to progress feeds to support healthy maturation and function of the immature gut while minimizing excessive and harmful inflammation. IQR (25th to 75th percentile). a Denominators for secondary outcomes vary due to deaths and missing data. b Unless otherwise specified. c Effect measure is median difference and P value from 2 sample Wilcoxon Rank Sum tests. d SDSs calculated by using The British 1990 growth reference (revised September 1996). These indicate how far an infant is from the population mean weight and head circumference for infants of the same age and gender. e Effect measure is the between group difference in change from birth (early versus late group) adjusted for baseline value. P value from analysis of covariance.
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